Loading clinical trials...
Loading clinical trials...
A Phase 2, Randomized, Controlled, Multicenter Study of Vosoritide in Children With Idiopathic Short Stature
Conditions
Interventions
Vosoritide Injection
Human Growth Hormone
+1 more
Locations
47
United States
Consano Clinical Research, LLC
California City, California, United States
Rady Children's Hospital - San Diego
California City, California, United States
Children's Hospital of Orange County Main Campus - Orange
California City, California, United States
Children's Hospital Los Angeles
Los Angeles, California, United States
Children's Hospital Oakland Research Institute
Oakland, California, United States
Center Of Excellence in Diabetes and Endocrinology
Sacramento, California, United States
Start Date
October 21, 2024
Primary Completion Date
June 1, 2026
Completion Date
December 1, 2036
Last Updated
March 13, 2026
NCT06309979
NCT01604395
NCT07450053
NCT05894876
NCT04020913
NCT02973061
Lead Sponsor
BioMarin Pharmaceutical
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions